Cargando…
Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797698/ https://www.ncbi.nlm.nih.gov/pubmed/20030869 http://dx.doi.org/10.1186/bcr2437 |
| _version_ | 1782175656569733120 |
|---|---|
| author | Smith, Ian E |
| author_facet | Smith, Ian E |
| author_sort | Smith, Ian E |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2797698 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27976982009-12-25 Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? Smith, Ian E Breast Cancer Res Short Communication BioMed Central 2009 2009-12-18 /pmc/articles/PMC2797698/ /pubmed/20030869 http://dx.doi.org/10.1186/bcr2437 Text en Copyright ©2009 BioMed Central Ltd |
| spellingShingle | Short Communication Smith, Ian E Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? |
| title | Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? |
| title_full | Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? |
| title_fullStr | Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? |
| title_full_unstemmed | Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? |
| title_short | Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy? |
| title_sort | do big1-98 and zofast demand a change in guidelines for endocrine therapy? |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797698/ https://www.ncbi.nlm.nih.gov/pubmed/20030869 http://dx.doi.org/10.1186/bcr2437 |
| work_keys_str_mv | AT smithiane dobig198andzofastdemandachangeinguidelinesforendocrinetherapy |